Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT)

Journal of Liposome Research

Volumn 9, Issue 1, 1999, Pages 53-79

  Johnsson, Markus ^a   Bergstrand, Nill ^a   Edwards, Katarina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bilayer discs; BNCT; Drug loading; Drug retention; Liposome

Indexed keywords

ACRIDINE; DISTEAROYLPHOSPHATIDIC ACID; DISTEAROYLPHOSPHATIDYLCHOLINE; MACROGOL; PHENANTHRIDINE DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; LIPID BILAYER; NEUTRON CAPTURE THERAPY; PH; PRECIPITATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0032913873     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109909044492     Document Type: Article

References (61)

1. Hawthorne, M.F. 1993. The role of chemistry in the development of boron neutron capture therapy of cancer. Angew Chem Int Ed Engl 32:950-984.
2. Chen, W., Mehta, S.C. and Lu, D.R. 1997. Selective boron drug delivery to brain tumors for boron neutron capture therapy. Adv Drug Del Rev 26:231-247.
3. Hartman, T. and Carlsson, J. 1994. Radiation dose heterogenity in receptor and antigen mediated boron neutron capture therapy. Radiother Oncol 31:61-75.
4. Laster, B.H., Kahl, S.B., Popenoe, E.A., Pate, D.W. and Fairchild, R.G. 1991. Biological efficacy of boronated low-density lipoprotein for boron neutron capture therapy as measured in cell culture. Cancer Res 51:4588-4593.
5. Gedda, L., Olsson, P., Pontén, J. and Carlsson, J. 1996. Development and in vitro studies of epidermal growth factor-dextrane conjugates for boron neutron capture. Bioconjug Chem 7:584-591.
6. Chen, C.J., Kane, R.R., Primus, F.J., Szalai, G., Hawthorne, M. F. and Shively, J.E. 1994. Synthesis and characterization of oligomeric nido-carboranyl phosphate diester conjugates to antibody and antibody fragments for potential use in boron neutron capture therapy of solid tumors. Bioconjug Chem 5:557-564.
7. Yanagië, H., Tomita, T., Kobayashi, H., Fujii, Y., Takahashi, T., Hasumi, K., Nariuchi, H. and Sekiguchi, M. 1991. Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br J Cancer 63:522-526.
8. 3]: Synthesis and liposomal delivery to murine tumors. Proc Natl Acad Sci 91:3029-3033.
9. Mehta, S.C., Lai, J.C.K. and Lu, D.R. 1996. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy. J Microencapsulation 13:269-279.
10. Hawthorne, M.F. and Shelly, K. 1997. Liposomes as drug delivery vehicles for boron agents. J Neuro-Oncology 33:53-58.
11. Gabizon, A., Price, D.C., Huberty, J., Bresalier, R.S. and Papahadjopoulos, D. 1990. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res 50:6371-6378.
12. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.-D., Woodle, M.C., Lasic, D.D., Redemann, C. and Martin, F.J. 1991. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor efficacy. Proc Natl Acad Sci 88:11460-11464.
13. Bakker-Woudenberg, I.A.J.M., Lokerse, A.F., ten Kate, M.T., Mouton, J.W., Woodle, M.C. and Storm, G. 1993. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumonia-infected lung tissue. J Infect Dis 168: 164-171.
14. Oku, N., Namba, Y. and Okada, S. 1992. Tumor accumulation of novel RES-avoiding liposomes. Biochim Biophys Acta 1126:255-260.
15. Woodle, M.C. and Lasic, D.D. 1992. Sterically stabilized liposomes. Biochim Biophys Acta 1113:171-199.
16. Forssen, E.A., Coulter, D.M. and Proffitt, R.T. 1992. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res 52:3255-3261.
17. Allen, T.M., Hansen, C., Martin, F., Redemann, C. and Yau-Young, A. 1991. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half lives in vivo. Biochim Biophys Acta 1066:29-36.
18. Blume, G. and Cevc, G. 1990. Liposomes for the sustained drug release in vivo. Biochim Biophys Acta 1029:91-97.
19. Blume, G. and Cevc, G. 1993. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157-168.
20. Ceh, B., Winterhalter, M., Frederik, P.M., Vallner, J.J. and Lasic, D.D. 1997. Stealth( liposomes: from theory to product. Adv Drug Del Rev 24:165-177.
21. Lerman, L.S. 1961. Structural considerations in the interaction of DNA and acridines. J Mol Biol 3:18-30.
22. Waring, M.J. 1968. Drugs which affect the structure and function of DNA. Nature 219:1320-1325.
23. Denny, W.A., Cain, B.F., Atwell, G.J., Hansch, C., Panthananickal, A. and Leo, A. 1982. Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents. J Med Chem 25:276-315.
24. Crenshaw, J.M., Graves, D.E. and Denny, W.A. 1995. Interactions of acridine antitumor agents with DNA: Binding energies and groove preferences. Biochemistry 34: 13682-13687.
25. Cullis, P.M., Symons, M.C.R., Cohen, G.M. and Wardman, P. 1990. A general method for efficient drug delivery to DNA. Med Sci Res 18:87-88.
26. Cai, J. and Soloway, A.H. 1996. Synthesis of carboranyl polyamines for DNA targeting. Tetrahedron Lett 37:9283-9286.
27. Wakelin, L.P.G. and Waring, M.J. 1974. The unwinding of circular deoxyribonucleic acid by phenatridinium drugs: Structure-activity relations for the intercalation reaction. Mol Pharm 9:544-561.
28. Sobell, H.M., Tsai, C.-C., Jain, S.C. and Gilbert, S.G. 1977. Visualization of drugnucleic acid interactions at atomic resolution. J Mol Biol 114:333-365.
29. Gedda, L., Nilsson, P., Nyholm, K., Carlsson, J., Ghaneolhosseini, H., Sjöberg, S. and Pettersson, J. 1998. Binding of acridine and phenantridinium analogues in human glioma spheroids. Manuscript in preparation.
30. Ghaneolhosseini, H., Tjarks, W. and Sjöberg, S. 1997. Synthesis of boronated phenantridinium derivatives for potential use in boron neutron capture therapy (BNCT). Tetrahedron 53:17519-17526.
31. Ghaneolhosseini, H., Tjarks, W. and Sjöberg, S. 1998. Synthesis of novel boronated acridines- and spermidines as possible agents for BNCT. Tetrahedron 54:3877-3884.
32. Gabel, D., Foster, S. and Fairchild, R.G. 1987. The Monte Carlo simulation of the biological effect of the 10B(n,alpha)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiat Res 111:14-25.
33. Mayer, L.D., Bally, M.B., Hope, M.J. and Cullis, P.R. 1985. Uptake of antineoplastic agents into large unilamellar vesicles in respons to a membrane potential. Biochim Biophys Acta 816:294-302.
34. Madden, T.D., Harrigan, P.R., Tai, L.C.L., Bally, M.B., Mayer, L.D., Redelmeier, T.E., Loughrey, H.C., Tilcock, C.P.S., Reinish, L.W. and Cullis, P.R. 1990. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem Phys Lip 53:37-46.
35. Mayer, L.D., Tai, L.C.L., Bally, M.B., Mitilenes, G.N., Ginsberg, R.S. and Cullis, P.R. 1990. Characterization of liposomal systems containing doxorubicin entrapped in respons to pH gradients. Biochim Biophys Acta 1025:143-151.
36. Boman, N.L., Mayer, L.D. and Cullis, P.R. 1993. Optimization of the retention properties of vincristine in liposomal systems. Biochim Biophys Acta 1152:253-258.
37. Harrigan, P.R., Wong, K.F., Redelmeier, T.E., Wheeler, J.J. and Cullis, P.R. 1993. Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim Biophys Acta 1149:329-338.
38. Haran, G., Cohen, R., Bar, L.K. and Barenholz, Y. 1993. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim Biophys Acta 1151:201:215.
39. Edwards, K., Johnsson, M., Karlsson, G. and Silvander, M. 1997. Effect of polyethyleneglycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys J 73:258-266.
40. Silvander, M., Johnsson, M. and Edwards, K. 1998. Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. Accepted for publication in Chem Phys Lip
41. Bellare, J.R., Davis, H.T., Scriven, L.E. and Talmon, Y. 1988. Controlled environment vitrification system (CEVS): an improved sample preparation technique. J Electron Microsc Tech 10:87-111.
42. Dubochet, J., Adrian, M., Chang, J.J., Homo, J.C., Lepault, J., McDowall, A.W. and Schultz, P. 1988. Cryo-electron microscopy of vitrified specimens. Q Rev Biophys 21:129-228.
43. Bligh, E.G. and Dyer, W.J. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
44. Stewart, J.C.M. 1980. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10-14.
45. Fry, D.W., White, J.C., Goldman, I.D. 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem 90:809-815.
46. Silvander, M. and Edwards, K. 1996. A method to detect leakage of DNA intercalators through liposome membranes. Anal Biochem 242:40-44.
47. Lasic, D.D., Frederik, P.M., Stuart, M.C.A., Barenholz, Y. and McIntosh, T.J. 1992. Gelation of liposome interior. A novel method for drug encapsulation. FEBS LETT 312:255-258.
48. Lasic, D.D., Ceh, B., Stuart, M.C.A., Guo, L., Frederik, P.M. and Barenholz, Y. 1995. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. Biochim Biophys Acta 1239:145-156.
49. Ceh, B. and Lasic, D.D. 1995. A rigorous theory of remote loading of drugs into liposomes. Langmuir 11:3356-3368.
50. Ceh, B. and Lasic, D.D. 1997. A rigorous theory of remote loading of drugs into liposomes: Transmembrane potential and induced pH-gradient loading and leakage of liposomes. J Colloid Interface Sci 185:9-18.
51. Amselem, S., Gabizon, A. and Barenholz, Y. 1990. Optimization and upscaling of doxorubicin-containing liposomes for clinical use. J Pharm Sci 79:1045-1052.
52. Lasic, D.D. 1982. A molecular model for vesicle formation. Biochim Biophys Acta 692:501-502.
53. Fromherz, P. 1983. Lipid-vesicle structure: size control by edge-active agents. Chem. Phys. Lett 94:259-266.
54. Edwards, K. and Almgren, M. 1992. Surfactant-induced leakage and structural change of lecithin vesicles: effect of surfactant headgroup size. Langmuir 8:824-832.
55. Edwards, K., Gustafsson, J., Almgren, M. and Karlsson, G. 1993. Solubilization of lecithin vesicles by a cationic surfactant: intermediate structures in the vesicle-micelle transition observed by cryo-transmission electron microscopy. J Colloid Interface Sci 161:299-309.
56. Uster, P.S., Allen, T.M., Daniel, B.E., Mendez, C.J., Newman, M.S. and Zhu, G.Z. 1996. Insertion of poly(ethylene glycol) derivatized phospholipid into preformed liposomes results in prolonged in vivo circulation time. FEBS LETT 386:243-246.
57. Webb, M.S., Harasym, T.O., Masin, D., Bally, M.B. and Mayer, L.D. 1995. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. Br J Cancer 72:896-904.
58. Lelkes, P.I. and Friedmann, P. 1984. Stabilization of large multilamellar liposomes by human serum in vitro. Biochim Biophys Acta 775:395-401.
59. Ueno, M. 1989. Partition behavior of a nonanionic surfactant, octyl glucoside, between membrane and water phases, and its effect on membrane permeability. Biochemistry 28:5631-5634.
60. Ruiz, J., Goni, F.M. and Alonso, A. 1988. Surfactant-induced release of liposomal contents - a survey of methods and results. Biochim Biophys Acta 937:127-134.
61. Edwards, K. and Almgren, M. 1990. Kinetics of surfactant-induced leakage and growth of unilamellar vesicles. Progr Colloid Polym Sci 82:190-197.